Conundrums and Opportunities with Anticoagulation in CAD, PAD, and VTE

Join recogonized leaders as they share the latest evidence and clinical practice pearls for managing patients with CAD, PAD, and VTE.

Live Meeting
2.00 available credits
Information
October 31, 2019
06:00 PM - 08:30 PM EDT
Gaylord National Resort and Convention Center
Room: National Harbor 12-13, 201 Waterfront Street, National Habor, Maryland, United States
Conundrums and Opportunities with Anticoagulation in CAD, PAD, and VTE
Choose a format
Details
Presenters
Related
Comments
  • Overview

    This live activity will feature nationally recognized leaders in managing anticoagulation in patients with coronary artery disease (CAD), peripheral artery disease (PAD) and venous thromboembolism (VTE) sharing the latest evidence and clinical practice pearls to managed care pharmacists. Discussion on the Managed Care Pharmacists role in chronic management of polyvascular disease will feature guidelines, economics and a pharmacy checklist on anticoagulation that will incorporate the guidelines, recent data, and managed care implications to give attendees an educated framework for their decision making in this area. 

  • Learning Objectives

    Upon completion of these activities, learners should be better able to:

    • Describe the rationale for combining an anticoagulant with antiplatelet therapy after stenting
    • Relate the clinical implications of anticoagulation in CAD, PAD, and VTE based on recent data
    • Utilize NOACs at the proper dose for patients with moderate or high risk of stroke, advising patients of the risks and benefits, and performing proper follow-up
    • Apply guideline recommendations for secondary prevention of CAD after ACS or PCI with antiplatelet and anticoagulation therapy based on recent data
  • Program Schedule

    6:00 PM Registration and Buffet Dinner

    6:30 PM Welcome and Introductions

    6:40 PM NOACs in Chronic CAD, PAD and VTE: Putting Data into Perspective

    7:20 PM Managed Care Pharmacists’ Role in the Chronic Management of Polyvascular Disease 

    7:50 PM Discussion and Q&A

    8:10 PM Question and Answer: Personalization of Care in Polyvascular Disease 

    8:25 PM Closing Remarks 

    8:30 PM Adjourn

  • Target Audience

    This activity is designed to meet the educational needs of managed care pharmacists, administrators and medical directors, physicians and nurses, national account managers, health economics and outcomes research staff.

  • Accreditation and Credit Designation Statements

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Global Learning Collaborative (GLC). The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

    CREDIT DESIGNATION
    Physicians
    The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Pharmacists
    This program has been developed according to the ACPE Criteria for Quality and is assigned ACPE Universal Activity #0797-9999-19-109-L01-P. This program is designated for up to 2.0 contact hours (0.2 CEUs) of continuing pharmacy education credit.

  • Commercial Support

    This activity is supported by an independent educational grant from Janssen Biotech, Inc, administered by Janssen Scientific Affairs, LLC.

  • ADA Statement

    Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Jessica McGrory prior to the live event at jmcgrory@omnia-prova.com.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

Details
Presenters
Related
Comments
  • Overview

    This live activity will feature nationally recognized leaders in managing anticoagulation in patients with coronary artery disease (CAD), peripheral artery disease (PAD) and venous thromboembolism (VTE) sharing the latest evidence and clinical practice pearls to managed care pharmacists. Discussion on the Managed Care Pharmacists role in chronic management of polyvascular disease will feature guidelines, economics and a pharmacy checklist on anticoagulation that will incorporate the guidelines, recent data, and managed care implications to give attendees an educated framework for their decision making in this area. 

  • Learning Objectives

    Upon completion of these activities, learners should be better able to:

    • Describe the rationale for combining an anticoagulant with antiplatelet therapy after stenting
    • Relate the clinical implications of anticoagulation in CAD, PAD, and VTE based on recent data
    • Utilize NOACs at the proper dose for patients with moderate or high risk of stroke, advising patients of the risks and benefits, and performing proper follow-up
    • Apply guideline recommendations for secondary prevention of CAD after ACS or PCI with antiplatelet and anticoagulation therapy based on recent data
  • Program Schedule

    6:00 PM Registration and Buffet Dinner

    6:30 PM Welcome and Introductions

    6:40 PM NOACs in Chronic CAD, PAD and VTE: Putting Data into Perspective

    7:20 PM Managed Care Pharmacists’ Role in the Chronic Management of Polyvascular Disease 

    7:50 PM Discussion and Q&A

    8:10 PM Question and Answer: Personalization of Care in Polyvascular Disease 

    8:25 PM Closing Remarks 

    8:30 PM Adjourn

  • Target Audience

    This activity is designed to meet the educational needs of managed care pharmacists, administrators and medical directors, physicians and nurses, national account managers, health economics and outcomes research staff.

  • Accreditation and Credit Designation Statements

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Global Learning Collaborative (GLC). The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

    CREDIT DESIGNATION
    Physicians
    The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Pharmacists
    This program has been developed according to the ACPE Criteria for Quality and is assigned ACPE Universal Activity #0797-9999-19-109-L01-P. This program is designated for up to 2.0 contact hours (0.2 CEUs) of continuing pharmacy education credit.

  • Commercial Support

    This activity is supported by an independent educational grant from Janssen Biotech, Inc, administered by Janssen Scientific Affairs, LLC.

  • ADA Statement

    Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Jessica McGrory prior to the live event at jmcgrory@omnia-prova.com.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

Register

We’re glad to see you’re enjoying Medtelligence…
but how about a more personalized experience?

Register for free